Literature DB >> 1690491

Recent progress in interferon research: molecular mechanisms of regulation, action, and virus circumvention.

J L Taylor1, S E Grossberg.   

Abstract

A complex system of cis regulatory elements exists by which induction of IFN gene expression is initiated in response to a variety of inducers; cis elements also appear to be involved in the down-regulation of IFN production. IFN gene activation or inhibition of expression may be tightly regulated by the specific binding of newly synthesized or modified proteins to be regulatory regions of the IFN genes. IFN itself acts as a potent modulator of multiple cellular activities. By binding to specific cell surface receptors and probable internalization via receptor-mediated endocytosis and transport into the dense chromatin, IFN treatment leads to activation of numerous genes, some of which possess known antiviral or immunoregulatory functions, whereas the function of others remains to be identified. As with the IFN genes themselves, many of the IFN-inducible genes appear to possess complex regulatory mechanisms, including domains for binding of specific trans-acting proteins. To add to this molecular complexity some viruses have successfully developed methods to circumvent, among other mechanisms, the 2',5'-A-mediated system and the P1 protein kinase system.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690491     DOI: 10.1016/0168-1702(90)90010-9

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  10 in total

1.  New sandwich-type enzyme-linked immunosorbent assay for human MxA protein in a whole blood using monoclonal antibodies against GTP-binding domain for recognition of viral infection.

Authors:  Mizuho Kawamura; Akira Kusano; Akiko Furuya; Nobuo Hanai; Hideki Tanigaki; Akihito Tomita; Akira Horiguchi; Kyosuke Nagata; Toshiko Itazawa; Yuichi Adachi; Yoshie Okabe; Toshio Miyawaki; Hiroaki Kohno
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

2.  The mechanism of poly I:C-induced antiviral activity in peritoneal macrophage.

Authors:  S Pyo
Journal:  Arch Pharm Res       Date:  1994-04       Impact factor: 4.946

3.  Gamma-radiation upregulates MHC class I/II and ICAM-I molecules in multiple myeloma cell lines and primary tumors.

Authors:  Maurizio Chiriva-Internati; Fabio Grizzi; Justin Pinkston; K John Morrow; Nicholas D'Cunha; Eldo E Frezza; Pier Carlo Muzzio; W Martin Kast; Everardo Cobos
Journal:  In Vitro Cell Dev Biol Anim       Date:  2006 Mar-Apr       Impact factor: 2.416

4.  Interferon-alpha (IFN-alpha) production by human intestinal mononuclear cells. Response to virus in control subjects and in Crohn's disease.

Authors:  M R Capobianchi; S Fais; F Mercuri; M Boirivant; F Dianzani; F Pallone
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis.

Authors:  K Sandberg; M L Eloranta; I L Campbell
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter.

Authors:  K C Chang; E Hansen; L Foroni; J Lida; G Goldspink
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Protective effect of interferon beta on human T cell leukaemia virus type I infection of CD4+ T cells isolated from human cord blood.

Authors:  B Macchi; I Faraoni; A Mastino; C D'Onofrio; G Romeo; E Bonmassar
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

Review 8.  Type I Interferon Is a Catastrophic Feature of the Diabetic Islet Microenvironment.

Authors:  Brittney N Newby; Clayton E Mathews
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-14       Impact factor: 5.555

9.  Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2.

Authors:  K L Chong; L Feng; K Schappert; E Meurs; T F Donahue; J D Friesen; A G Hovanessian; B R Williams
Journal:  EMBO J       Date:  1992-04       Impact factor: 11.598

Review 10.  Picornavirus inhibitors.

Authors:  L Carrasco
Journal:  Pharmacol Ther       Date:  1994       Impact factor: 12.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.